Startup launched by 3 UC scientists, including husband of Nobel laureate Jennifer Doudna, hires CEO

The South San Francisco company hopes to selectively target and kill off aberrant proteins as they’re being made, offering an early answer to a cause of cancers and other diseases.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks